Market capitalisation, EUR | 759.57 m |
EPS, EUR | -3.16 |
P/B ratio | 3.22 |
P/E ratio | - |
Dividend yield | 0.00% |
Revenue, EUR | 259.30 m |
Net income, EUR | -176.01 m |
Profit margin | -67.88% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.29% | Equity World Social/Environmental Innovation | 358 | 0.60% | 4 | +5.08% | A3DHPA | IE000VTOHNZ0 |
ARK Genomic Revolution UCITS ETF USD Accumulating | 6.57% | Equity World Health Care Innovation | 39 | 0.75% | 3 | - | A408AY | IE000O5M6XO1 |
Global X Genomics & Biotechnology UCITS ETF | 1.49% | Equity World Health Care Biotech | 41 | 0.50% | 7 | -4.03% | A2QRCP | IE00BM8R0N95 |
iShares Healthcare Innovation UCITS ETF | 0.11% | Equity World Health Care Social/Environmental Innovation | 195 | 0.40% | 1,022 | +4.73% | A2ANH2 | IE00BYZK4776 |
Xtrackers Russell 2000 UCITS ETF 1C | 0.03% | Equity United States Small Cap | 1,443 | 0.30% | 950 | +17.99% | A1XEJT | IE00BJZ2DD79 |
SPDR Russell 2000 US Small Cap UCITS ETF | 0.02% | Equity United States Small Cap | 1,776 | 0.30% | 2,674 | +18.01% | A1XFN1 | IE00BJ38QD84 |
L&G Healthcare Breakthrough UCITS ETF USD Acc | 1.57% | Equity World Health Care Innovation | 68 | 0.49% | 65 | -4.88% | A2PM51 | IE00BK5BC677 |